Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. (SHE:301126)
China · Delayed Price · Currency is CNY 8.90
-0.12 (-1.33%)
At close: Oct 29, 2026
SHE:301126 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 288.34 | 586.73 | 619.85 | 649.4 | 543 | 748.07 |
Trading Asset Securities | 14.82 | 9.82 | - | - | 100 | - |
Cash & Short-Term Investments | 303.16 | 596.55 | 619.85 | 649.4 | 643 | 748.07 |
Cash Growth | -40.42% | -3.76% | -4.55% | 1.00% | -14.05% | 226.70% |
Accounts Receivable | 1,970 | 2,074 | 1,817 | 1,693 | 1,538 | 1,447 |
Other Receivables | 362.73 | 134.54 | 98.33 | 98 | 118.06 | 110.83 |
Receivables | 2,332 | 2,209 | 1,915 | 1,791 | 1,656 | 1,558 |
Inventory | 927.14 | 932.63 | 858.29 | 629.11 | 433.21 | 250.28 |
Prepaid Expenses | - | - | 0.54 | 1.62 | 2.55 | 0.18 |
Other Current Assets | 325.8 | 233.51 | 317.79 | 243.29 | 276.96 | 90.49 |
Total Current Assets | 3,889 | 3,971 | 3,711 | 3,314 | 3,011 | 2,647 |
Property, Plant & Equipment | 927.95 | 961.94 | 964.08 | 719.81 | 529.1 | 285.59 |
Long-Term Investments | 16.92 | 66.92 | 123.6 | 122.53 | 20 | - |
Goodwill | 1,117 | 1,089 | 1,117 | 717.93 | 174.41 | - |
Other Intangible Assets | 107.99 | 112.49 | 135.72 | 138.17 | 103.55 | 25.83 |
Long-Term Deferred Tax Assets | 71.92 | 65.95 | 42.73 | 30.09 | 13.77 | 9.79 |
Long-Term Deferred Charges | 50.03 | 51.04 | 48.34 | 36.96 | 30.46 | 18.48 |
Other Long-Term Assets | 0.18 | 18.6 | 35.01 | 198.1 | 48.72 | 7.82 |
Total Assets | 6,180 | 6,337 | 6,178 | 5,278 | 3,931 | 2,994 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 849.86 | 812.65 | 707.18 | 496.21 | 367.64 | 413.7 |
Accrued Expenses | 33.42 | 63.13 | 50.7 | 43.97 | 39.51 | 26.92 |
Short-Term Debt | 2,419 | 2,421 | 1,884 | 1,521 | 1,198 | 589.25 |
Current Portion of Long-Term Debt | 291.52 | 442.99 | 299.09 | 65.16 | 86.6 | 4 |
Current Portion of Leases | - | 85.26 | 83.3 | 48.09 | 26.99 | 9.91 |
Current Income Taxes Payable | 32.01 | 10.7 | 22.22 | 17.32 | 25.49 | 30.34 |
Current Unearned Revenue | 93.26 | 51.84 | 71.89 | 21.16 | 10.97 | 76.13 |
Other Current Liabilities | 114.4 | 108.28 | 185.72 | 341.21 | 59.01 | 14.67 |
Total Current Liabilities | 3,833 | 3,996 | 3,305 | 2,555 | 1,814 | 1,165 |
Long-Term Debt | 580.98 | 604.95 | 885.85 | 833.75 | 211.46 | 106.14 |
Long-Term Leases | 110.22 | 117.44 | 133.49 | 105.62 | 87.24 | 44.11 |
Long-Term Unearned Revenue | 16.85 | 15.65 | 0.04 | 0.09 | - | - |
Long-Term Deferred Tax Liabilities | 9.85 | 9.85 | 5.51 | 1.98 | 1.18 | - |
Total Liabilities | 4,551 | 4,744 | 4,329 | 3,496 | 2,114 | 1,315 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 205.4 | 205.4 | 205.4 | 206.51 | 206.51 | 206.51 |
Additional Paid-In Capital | 980.94 | 980.94 | 980.94 | 989.84 | 994.55 | 994.55 |
Retained Earnings | 313.89 | 304.15 | 567.9 | 549.58 | 521.27 | 478.09 |
Comprehensive Income & Other | -2.63 | -2.63 | 2.54 | 1.3 | - | - |
Total Common Equity | 1,498 | 1,488 | 1,757 | 1,747 | 1,722 | 1,679 |
Minority Interest | 131.44 | 105.08 | 91.92 | 34.42 | 94.9 | - |
Shareholders' Equity | 1,629 | 1,593 | 1,849 | 1,782 | 1,817 | 1,679 |
Total Liabilities & Equity | 6,180 | 6,337 | 6,178 | 5,278 | 3,931 | 2,994 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 3,402 | 3,672 | 3,286 | 2,574 | 1,610 | 753.41 |
Net Cash (Debt) | -3,098 | -3,075 | -2,666 | -1,925 | -967.4 | -5.34 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -15.08 | -14.97 | -13.04 | -9.54 | -4.73 | -0.03 |
Filing Date Shares Outstanding | 205.4 | 205.4 | 205.4 | 206.51 | 206.51 | 206.51 |
Total Common Shares Outstanding | 205.4 | 205.4 | 205.4 | 206.51 | 206.51 | 206.51 |
Working Capital | 55.19 | -24.67 | 406.8 | 759.51 | 1,197 | 1,482 |
Book Value Per Share | 7.29 | 7.24 | 8.55 | 8.46 | 8.34 | 8.13 |
Tangible Book Value | 272.85 | 286.82 | 503.76 | 891.13 | 1,444 | 1,653 |
Tangible Book Value Per Share | 1.33 | 1.40 | 2.45 | 4.32 | 6.99 | 8.01 |
Buildings | - | 735.12 | 696.23 | 413.71 | 368.48 | 255.49 |
Machinery | - | 246.56 | 219.73 | 149.73 | 115.06 | 34.84 |
Construction In Progress | - | 19.78 | 25.63 | 151.68 | 26.4 | 1.64 |